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There are conflicting results regarding the role of 
autoantibodies in the pathogenesis of vitiligo. To 
examine their irr vivo effect, human skin was trans-
planted onto nude mice injected with purified IgG 
obtained from patients with vitiligo and from con-
trols. The effect was evaluated by several techniques. 
Dihydroxyphenylalanine staining revealed a marked 
decrease in the number of melanocytes in skin 
grafted onto mice injected with patients' IgG. Direct 
immunofluorescence staining demonstrated the pres-
ence of human IgG throughout the epidermis in 
T he pathogenesis of vitiligo is unknown [1-3], al-thou.gh there is evid. en ce to sugges~ that it ?1ay be ~ue to an autoimmune process associated wtth specific autoantibodies against m e lanocytes [3,4] . The asso-ciation of vitiligo with conditions such as Hashimo-
to's thyroiditis, diabetes mellitus, p ernicious anemia, and Addison's 
disease [5-7] suggests that an autoimmune phenomenon is in-
volved. 
Antimelanocyte antibodies have been d etected in patients with 
vitiligo [3 ,4], but it is unclear whether these antibodies are patho-
genic in human vitiligo or whether they represent an epiphenom-
enon to melanocyte damage caused by other components, such as 
T lymphocytes. R ecently, several i11 vitro studies [8 ,9] have dem-
onstrated a role for these autoantibodies in the pathogenesis of the 
disease. 
We have now studied the role of antibodies in the pathogenesis 
of vitiligo after injection of purifie d IgG from patients with vitiligo 
into nude mice g rafted with human skin . We found a d ecreased 
density of m elanocytes not observed following injection of IgG 
from normal controls. A role for IgG in the pathogenesis of vitiligo 
is suggested by these results. 
MATEIUALS AND METHODS 
Patients Serum samples from 11 patients with genera lized and progres-
sive vitiligo were obtained for this study. All patients had a history of viti ligo 
for at least 2 years and the duration of their disease ranged from 2 to 27 yea rs 
(mean, 4. 7 yea rs) . N o patient received any systemic or psora len plus 
ultraviolet A therapy in the 6 months prior to donating skin and blood. 
Serum was pooled from the 11 patients , as well as from 11 age-matched 
controls. Skin of normal individuals was obtained from the remnants of 11 
age-matched healthy subjects undergoing surgical procedures. The skin of 
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specimens injected with purified IgG from vitiligo 
patients. No staining was observed when control IgG 
was injected. Electron microscopy studies demon-
strated a marked decrease in melanin pigmentation 
with only rare melanosomes and melanocytes de-
tected in grafts injected with patients' IgG. Thus all 
three techniques showed the destructive effect of 
vitiligo patients' serum on melanocytes. Our study 
highlights the important role of autoantibodies in the 
pathogenesis of vitiligo. Key wovds: l!itiligo/autoimtllll-
nitylautoalltibodies. J Invest DeJ·matol 105:683-686, 1995 
each subject was g rafted onto six nude tnice. An infonned consent \:vas 
obtained from all the individuals participating in the study. 
Animals Outbred CDl nude mice 2- 3 months of age were used in this 
study. The animals were obtained from the pathogen-free animal breeding 
facility at the Weizmann Institute and were raised in the pathogen-free 
animal fac ility of The Bruce Rappaport Faculty of Meclicine, Techn ion-
Israel Institute of Technology, Haif.1. A total of 66 mice were grafted with 
normal skin (n = 33) and vitiligo skin (n = 33). 
Purification oflgG The IgG fractions from the pooled serum of patients 
and control vo lunteers were prepared by either precipitation with 50% 
ammonium sulfate followed by ion-exchange chromatography, accord ing 
to standard techniques (1 OJ, or by affinity chromatography, using staphylo-
coccal protein A coupled to Sepharosc -4B (Pharmacia , Uppsala, Sweden) 
(11] . The total lgG fractions were dialyzed against phosphate-buffered sa line 
(PBS) (pH 7.2) , concentrated by ultrafi ltration (Amicon , Le,.,;ngton, MA). 
fi lter-sterili zed (Milex, Millipore, Bedford, M.A), and stored at - 7Q 0 C. 
FinallgG (90 mg/ ml) concentrations were measured by nephelometry using 
monospecific antihuman IgG (Beckman Instruments Kit. Clinical Instru-
ments Division, Brea, CA). Affinity-purified JgG were tested for lgA (0 .02 
mg/ml) or IgM (0 .05 mg/ml) contaminants by double immunodiffu-
sion (1 2] and for other protein contaminants by sodium dodecylsulfate-
polyacrylamide gel electrophoresis. 
Skin Grafting and. IgG Ad.ntinistration T he methodology for trans-
planting skin grafts to the nude mouse has been described previo usl y 
(1 3,14]. Briefly, split-thickness skin grafts of normal human skin obtained 
fi·om the anterio r aspect of the hand or leg were transplamed onto the 
subcutaneous tissue over the lateral thoracic cage of the mouse. Each mouse 
received only one graft. Graft sites were covered with petroleum-impreg-
nated gauze and standard adhesive bandages surgica ll y stapled to the ven tra l 
surface of the animals. 0.3 ml of pooled purified IgG of either viti ligo 
patients or contro l volun teers was given intraveno usly t\.vi cc a day for four 
consecutive days. Biopsy specimens were taken from the same skin graft at 
4, 24, and 48 h after the last injection (day 4). Specimens were frozen in 
liquid nitrogen for inununo Ru o rc sccncc studies. Spccin1cns obtained at 4 h 
after the injections were also prepared for dihydrox yphenylalanine (DOPA) 
and electron microscopy studies . Each slide was coded, and the examiners 
of the slides were unaware as to whether the slide was fron1 an anin1al 
treated with control or patient lgG . Six mice were grafted from the same 
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Table I. Distribution of DOPA-Positive Mclanocytcs per 
mm
2 in Human Epidermis Grafted onto Mice Treated 
with IgG Obtained from Normal and Vitiligo Patients 
Slcin Graft NormallgG" Vitiligo lgG" 
(Donor) (9.9 mg/gm) (1 0.3 mg/gm) 
1 823 :t 52.31' 187 :t 12.3 
2 741 :t 76.4 317 :!: 21 .4 
3 761 :t 27.4 241 :t 96.3 
4 870 :t 116.3 308 :t 87.5 
5 592 :t 53 177 :t 22.3 
6 722 :t 22.3 247 :t 63.4 
7 638 :t 92.4 307 :t 103.6 
8 731 :t 37.2 182 :t 15.7 
9 687 :t 76.3 327 :t 112.4 
10 697 :t 92.7 407 :!: 143.1 
11 887 :t 103 427 :t 162.6 
Mean' 740.8 :t 91 284 :t 86 
" Samples of each subject represent the sam e donor. Each number represents the 
m ean o f three mice injected with the same so urce of IgG. 
1
' Sta ndard deviation . 
" T he differen ce between the m ean number of m cl:m ocytcs pe r mm2 in the nonni11 
lgG-trcatcd g roup and the vitiligo IgG-treatcd group was found to be sib'ltifi cant (p < 
0.0001) . 
donor. T hree mice were injected with vitiligo IgG and the remaining three 
with lgG from normal volunteers. 
Immunofluorescence Study Pieces of the grafts were immediately 
frozen in liquid nitrogen , and mounted in OCT (Tissue Tek, Naperville, 
IL) . Four-micron-thick sections were cut and stored at -70°C until used. 
Prior to incubation with the conjugates, slides were dipped briefl y in PBS, 
pH 7 .2, to remove the OCT. Slides were incubated at room temperature for 
l-2 h in fluorescein isothiocyanate conjugate at a dilution of 1:250 in PBS. 
After incubation the slides were washed in PBS by gentle roclcing for 10 min 
and placed in deio nized water followed by a brief exposure to acetone at 
4°C. Slides were air dried , covere d with g lycerol ntouuting 1ncdium , and 
examined immediately o r stored in the dark at 4°C and viewed within 72 h. 
Analysis for DOPA-Positive Melanocytes Biopsies of slcin grafts 
taken 4 d after the last lgG or placebo injection were eva luated for 
enzymatically active mclanocytes as previously described [1 3, "14]. Briefly, 
the epidermis was separated by immersing the slcin in 2 N sodium bromide 
for 45 min at 37°C. Epidermal sheets were subsequentl y incubated with 
0.1% DOPA (L-3 ,4-dihydroxyphenylalanine, Sigma C hemica ls Co ., St. 
Louis, MO), PBS (pH 7.4) for 3 to 5 h at 37°C . Following incubation , the 
epidermal pieces were fixed in a 1 0% forma l saline solution, mounted on 
glass slices with the dcrmo-epidermal junction facing upward , and then 
examined and photographed using a Zeiss photomicroscopc Ill. Epidermal 
mclanocytes were counted in each specimen using an ocular grid in 1 0 
independent fields at X400 magotifi cations. T he average number of DOPA-
positive melanocytes was estimated per square millimeter of surf<o ce area 
[13 , 15]. 
Statistical analysis was carried out using the paired t test. 
Electron Microscopy Slcin samples taken 4 d after the last lgG and 
control injection were fixed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH 7 .4) and post-fixed with 2'/'o osmium tetroxide in the 
sam e bufFer. T he tissue was dehydrated in graded ethanol solu tions and 
embedded in Spurr. T he specimen blocks were coded, and ultra thin sections 
were then cut with an LKB microtome, picked up on copper grids, and 
stained w ith uran yl acetate and lead citrate . The tissue was th en cxan1incd 
in a blind fashion with an RCA EMU 4 electron microscope. 
RESULTS 
Decreased Mclanocytcs in Skin Grafted with Vitiligo IgG 
Administration of purified IgG from con tro l volunteers to the 
grafted mice did not alter distribution of m elanocytes, w h ereas IgG 
from viti ligo patients cause d a reduc tion in the m e lanocyte d ensi ty 
in gra fts. Table I de tails the mean melanocyte density in grafts from 
each donor. The m ean density in grafts treated with v itiligo IgG 
was a lways less than in those obtained from the same donor but 
trea ted with normallgG . The total mean number of m e lanocytes in 
the vitiligo l gG-treated grafts was significantly lower (284 :t 86) 
than in those trea ted with normal lgG (740 ± 91) (p < 0 .0001 ) . 
THE JO URNAL OF INVESTIGATIVE DEltMATOLOGY 
Figure 1. Melanocytes arc reduced in epidermal sheets treated 
with pooled lgG from patients with vitiligo. Decreased DOPA-
positive mclanocytes in the ep idermal sheet of normal skin treated witl1 
purified JgG obtained from vitiligo patients (A). co mpared to IgG from 
normal vo lunteers (13) . 13ar, l S J-Lm . 
T he DOPA sta ining of viti ligo IgG-trea ted g rafts revea led scatte red 
resid u al positive cell s within large areas devoid of sta ining (Fig 1A). 
In grafts from subjects 1, 5, and 8, the DOPA-positive m e lanocytes 
w ere observed primaril y in the ed ges of th e epide rmal sheets, 
whereas in g rafts of subjects 10 and 11 DOPA-positive melanocytes 
were found in the edges combin ed with some foci of ce lls 
throug h out the epiderma l sheets. This inhibitio n on m e lanogene ic 
activity was not observed in g rafts treated with purified lgG of the 
control indi v idu a ls (Fig 1B). 
IgG Deposits Arc Present in Grafted Skin by Immunofluo-
rescence Human lgG was present in g rafts of mice trea ted with 
purified lgG of v iti ligo pa tients. T he staining sh owed a character-
isti c widespread inte rcellul a r deposition throug ho ut the epide rmis 
that appeared to be a ce ll-surface patte rn . T his stainin g was 
observed m os tly in specimens obta ined 4 h after the last lgG 
injectio n . Absent o r weak staining was observed in all specimens 
sta in ed 24 or 48 h after the last inj ec tion. The IgG sta ining was 
observed on ly in g rafts treated with purified lgG (18 of 33) of 
patients and not of the control volunteers. Data n ot shown. 
Decreased Mclanosomcs and Mclanocytcs in Skin Grafted 
with Patients' IgG by Electron Microscopy Samples were 
examined in a blinded fa shion b y e lectron mic roscop y. T he samples 
from mice injec ted with lgG of n o rmal voluntee rs sh o wed a no rmal 
amount of m elanin pigmentation (Fig 2A) . T he re w e re m any type 
III and IV m e lanosomes fo rmin g compl exes w ithin a no rmal 
numbe r of m e lanocytes . Type IV m e lan osomes were a lso seen 
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F igure 2 . Pooled IgG from patients with vitiligo reduces the 
nuntbcr of ntclanosomcs in mclanocytcs of epidermal sheets. A n 
electron microscopy study was perfo rmed on grafted human skin 4 h after 
the last lgG injection . A, skin graft fro m a m ouse treated wi th contro l lgG 
shows numero us m elanosom es (m) with in th e keratinocytes (K) and 
mclanocytes (M). Bar, 3 ~-tm . B, Skin graft fro m a mouse treated w ith lgG 
from viti ligo serum. N ote a decrease in m elanosomes (m) in both kerati-
nocytcs (K) and m elanocytes (M). Bar, 2 f.t111 . 
w ithin keratinocytes . Samples from mice injected w ith v itiligo IgG 
show ed a m arked decrease in m elanin pigmentation (Fig 2B) . 
G rafts from this g roup h ad only rare ly de tectable m elanosom es and 
m elanocytes. Few scatte red ke ratinocytes w ere fo und to con tain 
sing le type III and IV m elan osom es . T his group also had a m oderate 
number of dermal m acro phages containing melan osom es . T here 
did no t appear to be an y alteration in the Langerhan s cell p opula-
tion in any of the samples . Cell ular debris including lysed m elano-
cytes w as o bserved w ithin the epidermis of trea ted grafts (Fig 3). 
DISCUSSIO N 
Previous studies have not resolved the pathogenesis of vitiligo. N or-
dhmd and colleagues w ere able to demonstrate specific cytolytic 
alterations in long- tem1 cultures of melan ocytes obtained from vitil-
ig inous sites, thus suggesting an inhetited defect of melanocytes as a 
primary abnormality in vitiligo. In other studies, dilated rough endo-
plasmic reticulum was found in m elan ocytcs cultured from nonnally 
pigm ented skin o f vitiligo patients [1 6]. As vitiligo is commonly 
associated with several autoimmune disorders charactetized by au-
toantibodies to specific organ s (5- 7, 17-20), it was proposed d1at 
vitiligo might be an antibody-mediated autoimmune disease. Indeed, 
sera from m ost patients with vitiligo contain an tim ela.nocyte antibodies 
(3,4,8,9,21]. R ecently, Song el nl demonstrated tile presence of 
autoantibodies again st tyTosinase, an enzym e important in m elanin 
fo rmation , in the sera of patienrs with vitiligo (22). 
To prove the role of autoantibodies, o ne must demonstrate that 
au toan tibodies found in patients w ith vitiligo take part in m elan o-
cyte damage and are no t m erely an epiphenom enon . Although 
studies supporting both concepts have been published (8, 16], we 
be lieve that the present study strongly favors the pa thogenic ro le of 
antimclanocyte antibody in the o bserved damage to m elan ocytes in 
vitiligo skin . 
Several recent studies (21 ,23] suppo rt the concep t that anti-
m elanocyte antibodies are involved in the pathogen esis of vitiligo . 
Fig ure 3. M e la nocyte damage produced by vitiligo p a tients ' 
pooled IgG. Melanocyte (M) fro m a skin graft in a mouse treated w ith 
vitiligo lgG examined by electron microscopy discloses an early stage of cell 
lys is w ith disruptio n of the cell n1 cn1branc (thick mTo r11s) and ex trusio n of a 
m clanosom c (m) and other cellular debris (d) (tlliu mwll's). Bnr. 3.7 f.t111 . 
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T hese reports show a close correlation between the titers of vitiligo 
antibo di es and disease ac ti vity. Furthermore, Norris el a/ [24] 
showed in an ;, 11 ilro study that anti-melanocyte antibodies can 
directl y damage melanocytes by two immunologic m echanism s: 
an tibody-med iated cytotox icity and compl em ent-m ediated lysis . 
Several i11 11itro studies d emonstrated a ro le for antibodies in 
m e lanocyte d es truction [8,9]. T he cytotoxicity for m elanocytes in 
vitili go depends primarily on antibodies directed against surface 
antigens rather than against cytoplasmi c antigens [9]. 
Anim al m o de ls of viti ligo have given confli cting results regarding 
m e lanocyte des tru ction. T he expression of viti ligo in Smyth chjck-
e ns can be suppressed by down-regulating the immune response 
[25,26]. Indeed , bursectomy produced a signifi cant delay in pig-
m e ntatio n loss [27]. a finding observed in many animal models of 
auto immunity. O n the other hand, in the C57BL/6j-mi"1'/mi"1' 
mouse, the depigm entatio n process is not re lated to the immune 
system [28]. Pigm ented skin of the mouse grafted onto nude mice 
became completely white, implying a primarily m elan ocytic dys-
function in the e tiology of the depigm entation process. This 
observation , however, is contrary to that observed in vitiliginous 
human skjn that becom es repigmented following transplantation 
[13]. T hu s, the depigmentation in mi ce may be due to different 
factors fro m that observed in humans. The animal and human 
studi es suggest that several m echanisms may be involved in depig-
m en tation. 
The immunoflourescence study did not all ow distinction be-
tween keratinocytes and m elanocytes. However, ultrastructural 
changes as well as DOPA staining patterns suggest that the purified 
IgG of vitiligo patients preferentially targets m elanocytes and not 
keratinocytes. A direct immunofluorescence study performed by 
Yu et a/ [10] showed IgG binding to keratinocytes in patients with 
active vitiligo. Patients' sera showed cytotoxicity for melanocytes, 
whereas antikeratinocyte antibodies m ay be th e result of cell death 
during di sease ac tivity and not pathogenic. Our study supports this 
hypothesis. 
In summary, this study, which mimics the i11 11i11o situation, 
suggests a primary rol e for autoantibodies, most probably anti -
m elanocyte, in the pathogenesis of vitiligo. 
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